Table 2.
Association between a one-unit increase in anti-PS and anti-DNA antibodies and SM criteria.
| Clinical Complications | Anti-PS Antibodies | Anti-DNA Antibodies | ||
|---|---|---|---|---|
| Odds Ratio (95% CI) | P value | Odds Ratio (95% CI) | P value | |
| Prostration | 0.93 (0.52, 1.67) | 0.813 | 0.75 (0.43, 1.30) | 0.306 |
| Coma | 0.59 (0.34, 1.04) | 0.067 | 0.70 (0.41, 1.18) | 0.180 |
| Repeated convulsions | 0.49 (0.25, 0.96) | 0.038 | 0.79 (0.44, 1.42) | 0.434 |
| Deep breathing | 1.68 (0.71, 3.97) | 0.234 | 1.20 (0.49, 2.96) | 0.692 |
| Acute kidney injury | 1.51 (0.85, 2.69) | 0.160 | 2.99 (1.68, 5.31) | <0.0001* |
| Jaundice | 1.32 (0.74, 2.36) | 0.341 | 1.90 (1.04, 3.44) | 0.034 |
| Shocka | — | — | — | — |
| Abnormal bleeding | 0.04 (0.0006, 3.16) | 0.151 | 0.70 (0.07, 7.12) | 0.763 |
| Laboratory Measures | Beta (95% CI) | P value | Beta (95% CI) | P value |
| Hemoglobin, g/dL | −1.04 (−1.63, −0.44) | 0.001* | −0.95 (−1.52, −0.38) | 0.001* |
| Lactate, mmol/L | 0.88 (−0.12, 1.87) | 0.083 | 1.31 (0.32, 2.30) | 0.010 |
| Glucose, mmol/L | −0.55 (−1.38, 0.28) | 0.192 | −0.73 (−1.56, 0.11) | 0.087 |
| Parasite Density/uL | −24767 (41267) | 0.549 | −34350 (39542) | 0.386 |
Logistic regression for clinical complications and linear regression for laboratory measures.
aModel unstable because event (n = 1).
*Significant following Holm’s correction for multiple comparisons (n = 22).